|
ANASOMA
Anastrazole
|
Film Coated Tablet
|
Tanzania
|
TAN 21 HM 0302
|
Registered/Compliant
|
|
AZACITIDINE
-
|
PARENTERAL ORDINARY DRY VIALS
100 MG/VIAL
|
Uganda
|
NDA/MAL/HDP/11891
|
Registered
|
|
DECITABINE
-
|
PARENTERAL ORDINARY INFUSION DRY VIALS/BOTTLES
50 MG/VIAL
|
Uganda
|
NDA/MAL/HDP/11893
|
Registered
|
|
ENZASTIK 40
Butylated Hydroxy Anisole 0.095 mg/capsule,Butylhydroxytoluene 0.065 mg/capsule,Caprylocaproylca Polyoxylglycerides 904.840 mg/capsule,Enzalutamide 40 mg,Gelatin (160 Bloom) 237 mg/capsule,Glycerine 71.50 mg/capsule,Opacode WB Black NS-78- 17821 Quantity Sufficient NA,Purified Water 184.97 mg/capsule,Sorbitol Sorbitan Solution 52.40 mg/capsule,Titanium dioxide 4.13 mg/capsule
|
Capsules
40
|
Tanzania
|
TAN 25 HM 0055
|
Registered/Compliant
|
|
Ertapik
Ertapenem Monosodium 1 g
|
Powder for solution for injection
|
Tanzania
|
TZ 18 H 0096
|
Registered/Compliant
|
|
IRINOTECAN HYDROCHLORIDE TRIHYDRATE
-
|
PARENTERAL ORDINARY INFUSION VIALS/BOTTLES
20 MG/ML
|
Uganda
|
NDA/MAL/HDP/11830
|
Registered
|
|
IRNIZET 100
Hydrochloric acid . ml/5ml,Irinotecan hydrochloride trihydrate equivalent to Irinotecan 100 mg/5 ml,Lactic Acid 4.5 mg/5 ml,Nitrogen . q.s,Sodium Hydroxide . q.s,Sorbitol 225 mg/5 ml,Water for injections . ml/5ml
|
Intravenous Infusion
20
|
Tanzania
|
TAN 21 HM 0418
|
Registered/Compliant
|
|
IRNIZET 100
Irinotecan 100mg/5ml
|
Concentrate for solution for infusion
|
Zambia
|
ZAMRA-HM-25-276
|
Registered/Compliant
|
|
IRNIZET 300
Chlorhexidine Hydrochloride 13.5 mg/15 ml,Hydrochloric acid . q.s,Irinotecan hydrochloride trihydrate equivalent to Irinotecan 300 mg/15 ml,Nitrogen . q.s,Sodium Hydroxide . q.s,Sorbitol 675 mg/15 ml,Sterilized Water for Injection . q.s
|
Solution for injection/concentrate for solution for infusion
300
|
Tanzania
|
TAN 21 HM 0415
|
Registered/Compliant
|
|
IRNIZET 40
Chlorhexidine Hydrochloride 1.8 mg/2 ml,Hydrochloric acid . q.s,Nitrogen . q.s,Sodium Hydroxide . q.s,Sorbitol 90 mg/2 ml,Water for Injection . q.s,irinotecan hydrochloride 40 mg/2 ml
|
Solution for injection/concentrate for solution for infusion
40
|
Tanzania
|
TAN 21 HM 0413
|
Registered/Compliant
|
|
LEDOBOOK 10
Croscarmellose Sodium 5.6 mg/Tab,Empty Hard gelatin capsule shells of size “4” having a green cap and yellow body . mg/capsule,Lactose Monohydrate 80 mg/Tab,Lenalidomide 10 mg,Magnesium stearate USP-NF/Ph.Eur. 0.8 mg/capsule,Microcrystalline cellulose (Pharmacel 102) 63.60 mg/Tab
|
Capsules
|
Tanzania
|
TAN 23 HM 0023
|
Registered/Compliant
|
|
Merogram 1000
Meropenem 1000 mg
|
Powder for solution for injection
1000
|
Tanzania
|
TZ13H246
|
Registered/Compliant
|
|
NINTEDANIB ESILATE
-
|
ORAL SOLID ORDINARY CAPSULES
150 MG
|
Uganda
|
NDA/MAL/HDP/11900
|
Registered
|
|
PACSITA 150
Capecitabine USP 150 mg
|
Film Coated Tablet
150
|
Tanzania
|
TZ 19 H 0390
|
Registered/Compliant
|
|
PACSITA 500
Capecitabine 500 mg
|
Tablet, coated
500
|
Tanzania
|
TZ 19 H 0389
|
Registered/Compliant
|
|
PEMETREXED DISODIUM HEMIPENTAHYDRATE
-
|
PARENTERAL RETARD DRY VIALS
100 MG/VIAL
|
Uganda
|
NDA/MAL/HDP/11688
|
Registered
|
|
PEXARITE 500
Hydrochloric acid q.s ml/vial,Mannitol (Pearlitol PF) 500.0 mg/vial,Nitrogen q.s ml/vial,Pemetrexed disodium Hemipentahydrate equivalent to Pemetrexed 500 mg,Sodium Hydroxide q.s ml/vial,Water for Injection q. s to 10.0 mL ml/vial
|
Powder for Infusion
500
|
Tanzania
|
TAN 25 HM 0147
|
Registered/Compliant
|
|
TAMOXIFEN CITRATE
-
|
ORAL SOLID ORDINARY FILM-COATED TABLETS
20MG
|
Uganda
|
NDA/MAL/HDP/11369
|
Registered
|
|
ZESBINA 200
- Glycerol (anhydrous) 58.50 mg/capsule,- Medium-chain triglycerides 0.0 q.s,Arachis oil, refined 298 mg/capsule,Gelatin (160 Bloom) 136.50 mg/capsule,Isopropyl Alcohol 0.0 mg/capsule,KIMTECH PURE W4Wipers 0.0 mg/capsule,Lecithin 2 mg/capsule,Opacode WB Black NS-78- 17821 0.0 q.s,Progesterone 200 mg,Purified Water 127.56 mg/Tab,Titanium dioxide 2.44 mg/capsule
|
Soft Gellatin Capsules
|
Tanzania
|
TAN 23 HM 0527
|
Registered/Compliant
|